Premier Fund Managers Ltd bought a new stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 176,738 shares of the medical research company’s stock, valued at approximately $11,763,000. A number […]

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) saw a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 7,700,000 shares, a drop of 6.3% from the October 15th total of 8,220,000 shares. Based on an average daily trading volume, of 6,070,000 shares, the days-to-cover […]

Simmons Bank lessened its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 90.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,587 shares of the medical research company’s stock after selling 35,633 shares during the […]